300 related articles for article (PubMed ID: 17316361)
1. Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.
Yang YC; Tsao YP; Ho TC; Choung IP
Int J Gynecol Cancer; 2007; 17(2):418-25. PubMed ID: 17316361
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor γ (PPARγ) agonists in HeLa cells.
Chang HK; Kim DS; Chae JJ; Kim M; Myong JP; Lee KH; Lee MW; Park TC
Biochem Biophys Res Commun; 2017 Jan; 482(4):843-848. PubMed ID: 27888104
[TBL] [Abstract][Full Text] [Related]
3. Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner.
Al-Alem L; Southard RC; Kilgore MW; Curry TE
PLoS One; 2011 Jan; 6(1):e16179. PubMed ID: 21283708
[TBL] [Abstract][Full Text] [Related]
4. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG
J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
Fujita M; Hasegawa A; Yamamori M; Okamura N
J Exp Clin Cancer Res; 2017 Jul; 36(1):91. PubMed ID: 28673319
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
[TBL] [Abstract][Full Text] [Related]
7. PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma.
Chaffer CL; Thomas DM; Thompson EW; Williams ED
BMC Cancer; 2006 Mar; 6():53. PubMed ID: 16519808
[TBL] [Abstract][Full Text] [Related]
8. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18).
Takenokuchi M; Saigo K; Nakamachi Y; Kawano S; Hashimoto M; Fujioka T; Koizumi T; Tatsumi E; Kumagai S
Acta Haematol; 2006; 116(1):30-40. PubMed ID: 16809887
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
Liu JJ; Liu PQ; Lin DJ; Xiao RZ; Huang M; Li XD; He Y; Huang RW
Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
[TBL] [Abstract][Full Text] [Related]
10. The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells.
Lovekamp-Swan T; Chaffin CL
Mol Cell Endocrinol; 2005 Apr; 233(1-2):15-24. PubMed ID: 15767042
[TBL] [Abstract][Full Text] [Related]
11. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.
Shiau CW; Yang CC; Kulp SK; Chen KF; Chen CS; Huang JW; Chen CS
Cancer Res; 2005 Feb; 65(4):1561-9. PubMed ID: 15735046
[TBL] [Abstract][Full Text] [Related]
12. [Effects of peroxisome proliferator-activated receptor-gamma ligand troglitazone on colon cancer cell growth].
Koirala K; Wan YL; Liu YC; Wang X; Cui W; Wang CL; Chen HN; Wang HY; Zhu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):385-8. PubMed ID: 16892143
[TBL] [Abstract][Full Text] [Related]
13. PPARγ ligands induce growth inhibition and apoptosis through p63 and p73 in human ovarian cancer cells.
Kim S; Lee JJ; Heo DS
Biochem Biophys Res Commun; 2011 Mar; 406(3):389-95. PubMed ID: 21329655
[TBL] [Abstract][Full Text] [Related]
14. Combinational effect of PPARγ agonist and RXR agonist on the growth of SGC7901 gastric carcinoma cells in vitro.
Liu Y; Zhu ZA; Zhang SN; Mou J; Liu L; Cui T; Pei DS
Tumour Biol; 2013 Aug; 34(4):2409-18. PubMed ID: 23605322
[TBL] [Abstract][Full Text] [Related]
15. [Pro-apoptotic effect of ciglitazone in leukemic HL-60 cells via PPARγ and P38 MAPK signaling pathway].
Liu JJ; Liu WD; Liu XD; Raj-Shrestha P; Liu PQ; Huang HQ; Wu CB; Wang CZ; Xu Y; Xiao RZ; Lin DJ; Huang RW
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(32):2270-4. PubMed ID: 21029675
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth.
Hamaguchi N; Hamada H; Miyoshi S; Irifune K; Ito R; Miyazaki T; Higaki J
Cancer Sci; 2010 Sep; 101(9):1955-64. PubMed ID: 20608936
[TBL] [Abstract][Full Text] [Related]
17. Disruption of ERalpha signalling pathway by PPARgamma agonists: evidences of PPARgamma-independent events in two hormone-dependent breast cancer cell lines.
Lecomte J; Flament S; Salamone S; Boisbrun M; Mazerbourg S; Chapleur Y; Grillier-Vuissoz I
Breast Cancer Res Treat; 2008 Dec; 112(3):437-51. PubMed ID: 18204896
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptors-gamma activator, ciglitazone, inhibits human melanocyte growth through induction of apoptosis.
Kang HY; Lee JY; Lee JS; Choi YM
Arch Dermatol Res; 2006 Apr; 297(10):472-6. PubMed ID: 16474974
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
Li M; Lee TW; Yim AP; Mok TS; Chen GG
J Cell Physiol; 2006 Nov; 209(2):428-38. PubMed ID: 16883598
[TBL] [Abstract][Full Text] [Related]
20. Cell death is induced by ciglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) agonist, independently of PPARγ in human glioma cells.
Lee MW; Kim DS; Kim HR; Kim HJ; Yang JM; Ryu S; Noh YH; Lee SH; Son MH; Jung HL; Yoo KH; Koo HH; Sung KW
Biochem Biophys Res Commun; 2012 Jan; 417(1):552-7. PubMed ID: 22177955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
